Expression of MDR1 and GST-pi in human soft tissue sarcomas: relation to drug resistance and biological aggressiveness

Ann Oncol. 1992 Jan;3(1):63-9. doi: 10.1093/oxfordjournals.annonc.a058073.

Abstract

Human soft tissue sarcomas (HSTS) in adults are a family of mesenchymal tumors characterized by high biological aggressiveness and general refractoriness to chemotherapy. A series of 36 HSTS, 24 untreated and 12 homogeneously treated with a presurgical chemotherapeutic regimen consisting of doxorubicin (intra-arterial) and iphosphamide (intra-vein), was analyzed for expression of MDR1 and the glutathione-S-transferase-pi (GST-pi) gene in order to identify molecular phenomena which may be implicated in the chemoresistance displayed by these tumors. The MDR1 gene was expressed in a greater percentage of drug-treated tumors and at higher levels than in untreated ones. By contrast, chemotherapeutic treatment has no effect on GST-pi mRNA expression. The GST-pi expression level (EL) was much higher in the HSTS with biologically aggressive features. In fact, significant correlations were observed between GST-pi and histologic grade (p = 0.01); aneuploidy (p less than 0.01); and histone H3 EL (p = 0.01), suggesting a possible causal relationship between GST-pi activity and biological aggressiveness in HSTS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • DNA / analysis
  • Drug Resistance / genetics*
  • Female
  • Flow Cytometry
  • Gene Expression / genetics*
  • Glutathione Transferase / genetics*
  • Histones / genetics
  • Humans
  • Isoenzymes / genetics*
  • Male
  • Middle Aged
  • Phenotype
  • RNA, Messenger / analysis
  • Sarcoma / genetics*
  • Soft Tissue Neoplasms / genetics*

Substances

  • Histones
  • Isoenzymes
  • RNA, Messenger
  • DNA
  • Glutathione Transferase